Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Ítems similars

• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
  per: Griffiths, G, et al.
  Publicat: (2009)
• Issues in data monitoring and interim analysis of trials.
  per: Grant, A, et al.
  Publicat: (2005)
• CANparent trial evaluation: second interim report
  per: Cullen, M, et al.
  Publicat: (2014)
• CANparent trial evaluation: First interim report
  per: Cullen, M, et al.
  Publicat: (2013)
• Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
  per: Masahide Oki, et al.
  Publicat: (2024-12-01)